论文部分内容阅读
目的观察贝复舒滴眼液治疗角膜病的临床疗效。方法选取医院收治的角膜病患者86例随机分为观察组和对照组,每组43例。对照组采取常规药物治疗,观察组在此基础上联合贝复舒滴眼液进行治疗,比较2组患者的临床效果和并发症发生率。结果观察组治疗总有效率为95.34%,高于对照组的76.74%(P<0.05);观察组并发症总发生率为4.64%,低于对照组的46.94%(P<0.01)。结论常规药物治疗的基础上联合贝复舒滴眼液治疗角膜病患者,治疗效果显著,不仅有助于提高患者的治疗总有效率,还可降低并发症发生率,安全性更高,值得临床推广应用。
Objective To observe the clinical efficacy of Beifu Shu eye drops in the treatment of corneal diseases. Methods Eighty-six patients with corneal diseases admitted to hospital were randomly divided into observation group and control group, with 43 cases in each group. The control group to take conventional drug treatment, the observation group on the basis of combination of befufush eye drops for treatment, the clinical efficacy and complication rates in two groups were compared. Results The total effective rate of observation group was 95.34%, higher than that of control group (76.74%, P <0.05). The total incidence of complications in observation group was 4.64%, which was lower than that of control group (46.94%, P <0.01). Conclusion Conventional drug therapy based on the combination of befufush eye drops in patients with corneal disease, the treatment effect is significant, not only helps to improve the patient’s total effective rate, but also reduce the incidence of complications, higher safety, it is worth clinical Promote the application.